Michelle Emiko Velasquez, LAC is a
Acupuncturist based in Altadena, California. Michelle Emiko Velasquez is licensed to practice in California (license number AC6225) and her current practice location is
151 Purple Sage Ln, Altadena, California. She can be reached at her office (for appointments etc.) via phone at
(818) 378-7642.
NPI number for Michelle Emiko Velasquez is 1841347010 and her current mailing address is 151 Purple Sage Ln, Altadena, California. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1841347010.
Healthcare Provider's Profile
Full Name | Michelle Emiko Velasquez |
---|
Gender | Female |
---|
Speciality | Acupuncturist |
---|
Location | 151 Purple Sage Ln, Altadena, California |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1841347010
- Provider Enumeration Date: 01/03/2007
- Last Update Date: 01/15/2015
Medical Identifiers
Medical identifiers for Michelle Emiko Velasquez such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1841347010 | NPI | - | NPPES |
ZZZ06832Z | Other | CA | UNITEDHEALTHCARE |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
171100000X | Acupuncturist | AC6225 (California) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michelle Emiko Velasquez is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Michelle Emiko Velasquez, LAC 151 Purple Sage Ln, Altadena, CA 91001-3946 Ph: (818) 378-7642 | Michelle Emiko Velasquez, LAC 151 Purple Sage Ln, Altadena, CA 91001-3946 Ph: (818) 378-7642 |
Reviews and Comments